biotech

This year's sell off in biotech stocks is starting to … – Business Insider

Myles Udland

Mar. 25, 2015, 2:55 PM
2,690
Flickr/Gonzalo IzaBiotech investors have been here before.Stocks are lower on Wednesday and the high-flying biotech sector is leading the way down, with the iShares ETF that tracks the sector falling more than 3%. And as the sector has weakened over the last several days, this sell off is starting to look at lot like the sell […]

Getting it Right (and Wrong) With Leveraged Biotech ETFs

In what looks like a sequel to March 2014, high-flying biotechnology stocks and exchange traded funds are retreating amid talk of frothy valuations and a biotech bubble.At least temporarily, Friday March 20 marked the top for several of the largest biotech ETFs. That is when big-name ETFs, such as the iShares Nasdaq Biotechnology ETF (IBB) , the largest biotech ETF, […]

Bubble Watch: Biotech Edition

The financial markets have been on the rise for the past six years. That can only mean that doom is around the corner. What financial bubble is waiting to pop, and destroy us? Today: biotech stocks.What Is the Next Bubble, and When Will it Pop? What Is the Next Bubble, and When Will it Pop? What Is the Next Bubble, […]

Bubble Watch: Biotech Edition – Gawker

The financial markets have been on the rise for the past six years. That can only mean that doom is around the corner. What financial bubble is waiting to pop, and destroy us? Today: biotech stocks.What Is the Next Bubble, and When Will it Pop? What Is the Next Bubble, and When Will it Pop? What Is the Next Bubble, […]

Here's how to protect your profits in biotech: Trader – CNBC.com

Here’s how to protect your profits in biotech: Trader
Susquehanna’s Stacey Gilbert thinks biotech could be due for a pullback. She lays out an options strategy to protect your biotech holdings.
It’s been a record-breaking run for biotech stocks, with the Nasdaq Biotech ETF, the IBB, up 18 percent this year alone and nearly 300 percent in the past five years. But […]

3 Biotech Stocks to Buy If the Sector Crashes

The biotech sector has been on a roll lately. The SPDR S&P Biotech ETF ; ;has more than tripled since the start of 2012, compared to “just” a 63% increase in the S&P 500 .Source: Jeff Kubina via Flickr .Are we in a bubble that’s about to pop? We’ll only know for sure if (when?) the sector pulls back.In the […]

Post Fed, Bernanke Is Now a Market Timer

Yellen was criticized a few months back for opining on the strength of biotech and social media stocks.  Those stocks got hit for a day, but then stormed back to make more highs. Yellen learned from her mistake and has gone quietly into the good night with regard to market predictions.  She continues to be as dovish as ever though, […]

Why the massive biotech rally could continue

Trading Nation: How hot can biotech get?
David Seaburg, Cowen & Co., and Ari Wald, Oppenheimer, join “Power Lunch” to discuss the biotech rally.
Biotech stocks have been on fire. The industry has risen 40 percent in the past year, and added 2.3 percent on Friday alone. This after drug giant Biogen reported positive results for a new Alzheimer’s drug, leading its […]

Biotech Stocks Soar Amid Positive News – Biogen Idec Inc …

Related BIIBStifel Downgrades Biogen Amid Concerns Of Lack Of Upcoming Data, OvervaluationBenzinga’s Top #PreMarket LosersIs Biogen Stock Worth Considering Right Now?(Seeking Alpha)Related GILDGilead Shares Tumble On Drug Warning; Baird Says BuyBenzinga’s Top #PreMarket LosersSeeking Alpha’s Biotech Weekly: Biogen’s Plaque Attack, Amgen Or Gilead?, And More(Seeking Alpha)A number of biotech stocks were soaring in Friday’s premarket following positive news.Biogen Idec Inc […]

Stocks are selling off — except for the one sector people are calling a bubble (XBI, IBB, CNDO, FOLD, BBLT, BIIB)

BloombergThe iShares Nasdaq Biotechnology ETF over 12 months
Stocks are selling off on Thursday after a post-Fed rally yesterday.
But biotech stocks are rallying, up nearly 2%. In fact, biotech stocks have been on fire all year. They’re up about 15% year-to-date.Last week, Max Nisen at Quartz wrote that while everyone is focusing on massive tech valuations, the biotech industry is where things […]